Company Overview of Sanofi-Aventis Pharma Inc.
Sanofi-Aventis Pharma Inc. discovers, develops, manufactures, and distributes prescribed pharmaceutical products. The company’s products include cardiology, oncology, rheumatology arthritis, diabetic, allergy, anti-infective, and osteoporosis drugs. It markets its products under the brand names such as Actonel, Allegra, Arava, Ketek, Renedil, and Taxotere. Sanofi-Aventis Pharma Inc. was formerly known as Aventis Pharma Inc. The company was founded in 1999 and is headquartered in Laval, Canada. Sanofi-Aventis Pharma Inc. operates as a subsidiary of Sanofi.
2150 St. Elzear Boulevard West
Laval, QC H7L 4A8
Founded in 1999
Key Executives for Sanofi-Aventis Pharma Inc.
Similar Private Companies By Industry
|9037136 Canada Inc.||Americas|
|AAA Heidelberg Inc.||Americas|
|Ab Biotech Inc.||Americas|
|AB Laboratories Inc.||Americas|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Sanofi-Aventis Pharma Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.